Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death
暂无分享,去创建一个
T. Graeber | P. Mischel | I. Mellinghoff | M. Teitell | A. Ribas | I. Vivanco | R. Lo | Hong Wu | N. Graham | E. Komisopoulou | M. Tahmasian | M.‐F. Zhu | Bitika Kohli | Evangelia Komisopoulou
[1] Vito Pistoia,et al. Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy , 2012, Science Translational Medicine.
[2] T. Golub,et al. Selective killing of cancer cells with a small molecule targeting stress response to ROS , 2011, Nature.
[3] A. Subramanian,et al. Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress , 2011, Proceedings of the National Academy of Sciences.
[4] Matteo Pellegrini,et al. Global Phosphoproteomics Reveals Crosstalk Between Bcr-Abl and Negative Feedback Mechanisms Controlling Src Signaling , 2011, Science Signaling.
[5] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[6] S. Nelson,et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation , 2010, Nature.
[7] H. Coller,et al. The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. , 2010, Genes & development.
[8] F. Miot,et al. The Nonphagocytic NADPH Oxidase Duox1 Mediates a Positive Feedback Loop During T Cell Receptor Signaling , 2010, Science Signaling.
[9] T. Graeber,et al. Activation of aortic endothelial cells by oxidized phospholipids: a phosphoproteomic analysis. , 2010, Journal of proteome research.
[10] Sang Gyun Kim,et al. Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. , 2010, Molecular cell.
[11] A. Munnich,et al. Calcium signalling-dependent mitochondrial dysfunction and bioenergetics regulation in respiratory chain Complex II deficiency , 2010, Cell Death and Differentiation.
[12] Paul S Mischel,et al. Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032 , 2010, Journal of Translational Medicine.
[13] Jing Chen,et al. Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth , 2009, Science Signaling.
[14] R. Deberardinis,et al. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. , 2009, Cancer research.
[15] K. Kinzler,et al. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.
[16] Diana Anderson,et al. Tks5-Dependent, Nox-Mediated Generation of Reactive Oxygen Species Is Necessary for Invadopodia Formation , 2009, Science Signaling.
[17] D. Spitz,et al. Glucose deprivation-induced metabolic oxidative stress and cancer therapy. , 2009, Journal of cancer research and therapeutics.
[18] Hanna Y. Irie,et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment , 2009, Nature.
[19] Paul S Mischel,et al. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis , 2009, Proceedings of the National Academy of Sciences.
[20] D. Spitz,et al. Mitochondrial electron transport chain blockers enhance 2-deoxy-D-glucose induced oxidative stress and cell killing in human colon carcinoma cells , 2009, Cancer biology & therapy.
[21] David M. Sabatini,et al. Tumours with PI3K activation are resistant to dietary restriction , 2009, Nature.
[22] L. Oberley,et al. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. , 2009, The Biochemical journal.
[23] K. Hashiguchi,et al. Establishment of human cell lines lacking mitochondrial DNA. , 2009, Methods in molecular biology.
[24] Shenmin Zhang,et al. A modified cysteinyl-labeling assay reveals reversible oxidation of protein tyrosine phosphatases in angiomyolipoma cells , 2008, Proceedings of the National Academy of Sciences.
[25] M. Yuneva. Finding an “Achilles’ heel” of cancer: The role of glucose and glutamine metabolism in the survival of transformed cells , 2008, Cell cycle.
[26] K. Khoo,et al. Redox regulation of the protein tyrosine phosphatase PTP1B in cancer cells , 2008, The FEBS journal.
[27] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[28] Nicola Zamboni,et al. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells , 2007, The Journal of cell biology.
[29] Hong Wu,et al. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. , 2007, Cancer cell.
[30] C. Dang,et al. Effects of hypoxia on tumor metabolism , 2007, Cancer and Metastasis Reviews.
[31] T. Graeber,et al. Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants , 2006, Proceedings of the National Academy of Sciences.
[32] Steven P Gygi,et al. A probability-based approach for high-throughput protein phosphorylation analysis and site localization , 2006, Nature Biotechnology.
[33] Jinsong Liu,et al. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. , 2006, Cancer cell.
[34] M. Ushio-Fukai. Localizing NADPH Oxidase–Derived ROS , 2006, Science's STKE.
[35] T. Cloughesy,et al. Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. , 2006, Cancer research.
[36] Benno Schwikowski,et al. Signal Maps for Mass Spectrometry-based Comparative Proteomics* , 2006, Molecular & Cellular Proteomics.
[37] F. Domann,et al. Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose. , 2006, Cancer research.
[38] G. Sarosi,et al. Subcellular targeting of oxidants during endothelial cell migration , 2005, The Journal of cell biology.
[39] T. Kawahara,et al. Point Mutations in the Proline-rich Region of p22phox Are Dominant Inhibitors of Nox1- and Nox2-dependent Reactive Oxygen Generation* , 2005, Journal of Biological Chemistry.
[40] R. Deberardinis,et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation , 2005, Oncogene.
[41] Michael Karin,et al. Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases , 2005, Cell.
[42] S. Flanagan,et al. Mitochondrial O2*- and H2O2 mediate glucose deprivation-induced stress in human cancer cells. , 2005, The Journal of biological chemistry.
[43] Kap-Seok Yang,et al. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[44] A. Alavi,et al. Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.
[45] Michael P. Myers,et al. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate , 2003, Nature.
[46] Toshiyuki Fukada,et al. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. , 2002, Molecular cell.
[47] Michael E Phelps,et al. Positron emission tomography scanning: current and future applications. , 2002, Annual review of medicine.
[48] L. Zhu,et al. Insulin-stimulated Hydrogen Peroxide Reversibly Inhibits Protein-tyrosine Phosphatase 1B in Vivo and Enhances the Early Insulin Action Cascade* , 2001, The Journal of Biological Chemistry.
[49] T. Galeotti,et al. A Redox Signaling Mechanism for Density-dependent Inhibition of Cell Growth* , 2000, The Journal of Biological Chemistry.
[50] R. Mamillapalli,et al. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases , 2000, Current Biology.
[51] H. Forman,et al. Dominant-negative Jun N-terminal protein kinase (JNK-1) inhibits metabolic oxidative stress during glucose deprivation in a human breast carcinoma cell line. , 2000, Free radical biology & medicine.
[52] L. Ridnour,et al. Glucose Deprivation‐Induced Oxidative Stress in Human Tumor Cells: A Fundamental Defect in Metabolism? , 2000, Annals of the New York Academy of Sciences.
[53] Y. Lee,et al. Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells. , 1999, Free radical biology & medicine.
[54] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[55] S. Rhee,et al. Reversible Inactivation of Protein-tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor* , 1998, The Journal of Biological Chemistry.
[56] D. Spitz,et al. Glucose Deprivation-induced Cytotoxicity and Alterations in Mitogen-activated Protein Kinase Activation Are Mediated by Oxidative Stress in Multidrug-resistant Human Breast Carcinoma Cells* , 1998, The Journal of Biological Chemistry.
[57] M. Wigler,et al. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[58] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[59] J. Yodoi,et al. Persistent oxidative stress in cancer , 1995, FEBS letters.
[60] C. Nathan,et al. Production of large amounts of hydrogen peroxide by human tumor cells. , 1991, Cancer research.
[61] C. White,et al. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. , 1988, The Journal of biological chemistry.
[62] T. Chou,et al. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. , 1984, Advances in enzyme regulation.
[63] S. Weinhouse. On respiratory impairment in cancer cells. , 1956, Science.